Wpg Advisers, LLC Apellis Pharmaceuticals, Inc. Transaction History
Wpg Advisers, LLC
- $107 Billion
- Q1 2025
A detailed history of Wpg Advisers, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Wpg Advisers, LLC holds 5 shares of APLS stock, worth $99. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5
Previous 5
-0.0%
Holding current value
$99
Previous $160,000
31.87%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding APLS
# of Institutions
295Shares Held
126MCall Options Held
930KPut Options Held
759K-
Wellington Management Group LLP Boston, MA12.3MShares$246 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.2MShares$244 Million4.32% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$238 Million20.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$202 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.63MShares$192 Million0.02% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.2B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...